Skip to main content
Clinical Trials/JPRN-UMIN000027859
JPRN-UMIN000027859
Completed
未知

Examination of the treatment prediction factor of Ombitasvir/Paritaprevir/Ritonavir in chronic hepatitis C of Genotype1b. - Examination of the treatment prediction factor of Ombitasvir/Paritaprevir/Ritonavir in chronic hepatitis C of Genotype1b.

ippon Medical School Chiba Hokusoh Hospital0 sites500 target enrollmentJune 22, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic hepatitis C
Sponsor
ippon Medical School Chiba Hokusoh Hospital
Enrollment
500
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 22, 2017
End Date
March 30, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ippon Medical School Chiba Hokusoh Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.History of allergy to Ombitasvir/Paritaprevir/Ritonavir 2\.Decompensated liver cirrhosis 3\.pregnant woman or lactating mother 4\.Hepatocellular carcinoma, or other malignant tumor. 5\.severe depression 6\.Judged by investigator not to be appropriate for inclusion in this study 7\.Receiving contraindicated drugs for Ombitasvir/Paritaprevir/Ritonavir combined therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials